昭衍新药
(603127)
| 流通市值：282.79亿 | | | 总市值：337.58亿 |
| 流通股本：6.28亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-10-30 | -331.10万 | -0.17% | 7689.59万 | 3.98% | 256.78万 | 0.13% | -7615.27万 | -3.94% |
| 2026-10-29 | -3089.12万 | -1.87% | 1012.30万 | 0.61% | 6676.31万 | 4.03% | -4599.49万 | -2.78% |
| 2026-10-28 | 6946.38万 | 4.29% | 6941.37万 | 4.28% | -4746.71万 | -2.93% | -9141.05万 | -5.64% |
| 2026-10-27 | -2485.02万 | -1.86% | 1118.53万 | 0.84% | 7735.59万 | 5.78% | -6369.11万 | -4.76% |
| 2026-10-26 | 39.97万 | 0.03% | 8836.14万 | 6.44% | 6588.16万 | 4.80% | -15464.27万 | -11.27% |
| 2026-10-23 | -585.40万 | -0.46% | 3941.16万 | 3.07% | 982.58万 | 0.76% | -4338.33万 | -3.38% |
| 2026-10-22 | -568.96万 | -0.41% | -3072.48万 | -2.22% | 6440.44万 | 4.66% | -2799.00万 | -2.02% |
| 2026-10-21 | -3403.71万 | -2.16% | -1815.75万 | -1.15% | -3539.32万 | -2.25% | 8758.78万 | 5.57% |
| 2026-10-20 | 33150.99万 | 13.81% | -7374.02万 | -3.07% | -16905.06万 | -7.04% | -8871.92万 | -3.70% |
| 2026-10-19 | -298.97万 | -0.16% | -1701.54万 | -0.89% | -6007.47万 | -3.13% | 8007.98万 | 4.17% |